NA | 28.5% Salicylic Acid [Elorac, Inc.] | BioPortfolio

12:26 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx only



This Product is a topical preparation containing 28.5% salicylic acid extended release in a proprietary film-forming virucidal solution composed of acrylates copolymer, butyl acetate, carthamus tinctorius seed oil, cocamidopropyl dimethylamine, ethylhexylglycerin, isopropyl alcohol, isopropyl-metacresol, olea europaea fruit oil, phenic acid, phenoxyethanol, polysorbate 80, polyvinyl butyral, trimethyl pentanyl diisobutyrate, and water. The pharmacologic activity of the Product is generally attributed to the keratolytic activity of salicylic acid, which is incorporated into a polyacrylic, film-forming virucidal solution designed to cover the wart without the need for a bandage. The structural formula of salicylic acid is:

Although the exact mode of action for salicylic acid in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses. This Product incorporates a unique patented extended release form of salicylic acid that provides for enhanced release of salicylic acid for over 24 hours.

The virucidal complex incorporated into this Products proprietary solution is designed to help reduce risk of reinfection at the wart site, as well as prevent viral contamination of the product under normal usage.

This Product is indicated for the topical treatment and removal of common warts and plantar warts.

Patients with diabetes or impaired blood circulation should not use the Product. This Product also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face.

This Product is for external use only. Do not permit it to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. The Product should not be allowed to contact normal skin surrounding the wart site, since localized irritation may occur. Treatment should be discontinued if excessive irritation occurs.

The Product is flammable. Keep away from fire or flame. Keep bottle tightly capped when not in use.

A localized irritant reaction may occur if this Product is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

Prior to applying the Product, soak wart in warm water for five minutes. Remove any loose tissue by gently rubbing with a washcloth, emery board, or pumice stone. Dry the wart site thoroughly. Using the brush applicator supplied, apply it twice to the entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day as directed by your healthcare provider. Be careful not to apply to surrounding skin.

Clinically visible improvement normally occurs during the first or second week of therapy. Resolution may be expected after four to six weeks of the Product use, though some warts may take longer to remove.

This Product is supplied in 10 mL amber bottles with a brush applicator (NDC 42783-324-10).

Store at 15° to 30°C (59° to 86°F).

Manufactured for:

Elorac, Inc.

Vernon Hills, IL 60061

U.S. Patent No. 6,979,440

Additional Patent Pending

© 2014 Elorac, Inc.



Your health care provider has prescribed this Product, a topical prescription preparation for the treatment of common warts and plantar warts. In order for it to work properly and to ensure maximum benefit, the following instructions should be followed carefully. Of course, as with any medication, always consult your health care provider if you experience any discomfort or unexpected reactions.





Repeat Step 1 and Step 2 once or twice daily as advised by the health care provider.

Clinically visible improvement will normally occur during the first or second week of therapy. Resolution may be expected after four to six weeks of the Product use, though some warts may take longer to remove.

Vernon Hills, IL 60061

NDC 42783-324-10

28.5% Salicylic Acid Extended Release Antiviral Film-Forming Solution

1/3 fl. oz. (10 mL)

Rx only

NDC 42783-324-10

28.5% Salicylic Acid Extended Release Antiviral Film-Forming Solution

1/3 fl. oz. (10 mL)

Rx only


Elorac, Inc.

Active Ingredients


Clinical Trials [2786 Associated Clinical Trials listed on BioPortfolio]

Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women

This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with ...

Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Comparing the Efficacy and Safety of Combined Glycolic Acid and Salicylic Acid Peel Versus Glycolic Acid Peel Alone in the Treatment of Melasma: A Split Face Study

Melasma is an acquired form of hyperpigmentation that is seen most commonly on the face, characterized by symmetrically distributed brown patches of variable darkness. The cosmetically una...

Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris

The concept behind our study was to combine an effect of antibiotic and anti-inflammatory agents for a more efficient acne therapy directed at the factors involved in the pathophysiology o...

Anti-programmed Cell Death-1 Ligand 1 (PDL-1) Antibody Atezolizumab, Bevacizumab and Acetyl Salicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

This is a randomized phase II study, aimed at evaluating the efficacy (through progression free survival at 6 months) and safety of 5 different treatments involving atezolizumab, bevacizum...

PubMed Articles [6464 Associated PubMed Articles listed on BioPortfolio]

Determination of Salicylic Acid in Feed Using LC-MS/MS.

Salicylic acid is a derivative of benzoic acid and occurs in nature. The main target of this study was to develop the liquid chromatography coupled with tandem mass spectrometry technique as a method ...

New salicylic acid and pyroglutamic acid conjugated derivatives confer protection to bread wheat against Zymoseptoria tritici.

To promote sustainable agriculture and healthy food, research that contributes towards a new generation of eco-friendly phytosanitary compounds are increasingly encouraged. The plant hormone salicylic...

Metabolic Alternations of Amino Acids, γ-Aminobutyric Acid, and Salicylic Acid in Solanum lycopersicum (L.) Following Preplanting Seedling Spray with Salicylic Acid.

Preplanting foliar spray of salicylic acid (SA) (0.0, 5.0, and 10.0 μg/mL) to Solanum lycopersicum (L.) altered the metabolite profile of amino acids, γ-aminobutyric acid (GABA), and SA in leaf, roo...

A pendant peptide endows a sunscreen with water-resistance.

Ultraviolet light causes skin cancer. Salicylic acid and other molecular filters absorb damaging radiation but are washed away readily. Conjugation to a collagen mimetic peptide is shown to retain sal...

Isoproturon-induced salicylic acid confers Arabidopsis resistance to isoproturon phytotoxicity and degradation in plants.

This study identified the effect of salicylic acid on degradation of isoproturon in Arabidopsis. Three T-DNA insertion mutant lines pal1-1, pal1-2 and eps1-1 defective in salicylic acid synthesis were...

Quick Search


Relevant Topics

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record